Fact CheckerSign in

Primary biliary cholangitis: open trials in China

16 open trials have a site in China. Registry data; only the trial team decides who can take part.

  • NCT06051617

    Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

    Trial Treatment · Phase 3 · Gilead Sciences

    Beijing Ditan Hospital, Capital Medical University, Beijing · Beijing YouAn Hospital,Capital Medical University, Beijing · Beijing Friendship Hospital, Capital Medical University, Beijing · The First Hospital of Jilin University, Changchun · West China Hospital of Sichuan University, Chengdu · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou · The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou · Guizhou Provincial People's Hospital, Guiyang · The First Affiliated Hospital of Anhui Medical University, Hefei · The First People's Hospital of Yunnan Province, Kunming · The Second Hospital of Nanjing, Nanjing · Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai · The First Affiliated Hospital of Xinjiang Medical University, Ürümqi · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · The First Affiliated Hospital of PLA Air Force Medical University, Xi'an · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang · Henan Provincial People's Hospital, Zhengzhou · The Third People's Hospital of Zhenjiang, Zhenjiang

    Registry updated 2026-11-02

  • NCT07296458

    FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

    Trial Treatment · Phase 3 · Xijing Hospital of Digestive Diseases

    Sun Yat-sen Memorial Hospital, Guangzhou · Xijing hospital, Xi'an

    Registry updated 2026-11-02

  • NCT02823366

    Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

    Trial Treatment · Phase 3 · Xijing Hospital of Digestive Diseases

    Xijing Hosipital, Xi'an

    Registry updated 2026-10-30

  • NCT06365424

    Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

    Trial Treatment · Phase 2/3 · Xijing Hospital of Digestive Diseases

    Xijing hospital, Xi'an

    Registry updated 2026-10-30

  • NCT06591468

    Registry updated 2026-10-29

  • NCT07795151

    Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis

    Trial Treatment · Phase 1/2 · Beijing 302 Hospital

    Beijing 302 Hospital, Beijing

    Registry updated 2026-08-31

  • NCT07733882

    Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression

    Research · Beijing Municipal Administration of Hospitals

    Beijing Ditan Hospital, Capital Medical University, Beijing

    Registry updated 2026-08-04

  • NCT07282353

    A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

    Trial Treatment · Phase 3 · Cascade Pharmaceuticals, Inc

    Baoji People's Hospital, Baoji · China-Japan Friendship Hospital, Beijing · Beijing YouAn Hospital,Capital Medical University, Beijing · Beijing Friendship Hospital, Capital Medical University, Beijing · The First Bethune Hospital of Jilin University, Changchun · Xiangya Hospital Central South University, Changsha · West China Hospital,Sichuan University, Chengdu · Chongqing University Three Gorges Hospital, Chongqing · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou · Hangzhou Xixi Hospital, Hangzhou · The Fourth Hospital of Harbin Medical University, Harbin · The First Affiliated Hospital of Anhui Medical University, Hefei · The First Affiliated Hospital of USTC(Anhui Provincial Hospital), Hefei · The Second Affiliated Hospital Of Anhui Medical University, Hefei · Linyi People's Hospital, Linyi · The First Affiliated Hospital of NanChang University, Nanchang · Jiangsu Province Hospital, Nanjing · The Second Hospital of Nanjing, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Ningbo Medical Center Li Huili Hospital, Ningbo · The Affiliated Hospital of Qingdao University, Qingdao · Shanghai Jiao Tong University School of Medicine - Ruijin Hospital, Shanghai · Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai · Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai · The First Hospital of China Medical University, Shenyang · Peking University Shenzhen Hospital, Shenzhen · Shenzhen Third People's Hospital, Shenzhen · Taihe Hospital of Shiyan, Shiyan · The Fifth People's Hospital of Suzhou, Suzhou · Taizhou Hospital of Zhejiang Province, Taizhou · Tianjin First Central Hospital, Tianjin · Tianjin Medical University General Hospital, Tianjin · Tianjin Third Central Hospital, Tianjin · Zhongnan Hospital of Wuhan University, Wuhan · The Fifth People's Hospital Of Wuxi, Wuxi · Xiamen Hospital of T.C.M., Xiamen · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · The Fourth People's Hospital of Qinghai Province, Xining · Affiliated Hospital of Guangdong Medical University, Zhanjiang · Henan Provincial People's Hospital, Zhengzhou · The Third People's Hospital of Zhenjiang, Zhenjiang

    Registry updated 2026-07-08

  • NCT07678645

    Registry updated 2026-07-01

  • NCT07449793

    Biochemical Response and Clinical Outcomes in Patients With PBC

    Research · RenJi Hospital

    RenJi Hospital, Shanghai

    Registry updated 2026-03-04

  • NCT05749822

    Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

    Trial Treatment · Phase 2/3 · Xijing Hospital of Digestive Diseases

    Peking Union Medical College Hospital, Beijing · Xiangya Hospital Central South University, Changsha · Sichuan Provincial People's Hospital, Chengdu · Sun Yat-sen Memorial Hospital, Guangzhou · The Second Affiliated Hospital of Kunming Medical University, Kunming · Jiangsu Province Hospital, Nanjing · The First Hospital of China Medical University, Shenyang · Tianjin Third Central Hospital, Tianjin · Tianjin Medical University General Hospital, Tianjin · Xijing hospital, Xi'an · Yan'an University Affiliated Hospital, Yan’an · Henan Provincial People's Hospital, Zhengzhou

    Registry updated 2026-01-08

  • NCT05751967

    Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

    Trial Treatment · Phase 3 · Xijing Hospital of Digestive Diseases

    Sichuan Provincial People's Hospital, Chengdu · Sun Yat-sen Memorial Hospital, Guangzhou · The Second Hospital of Lanzhou University, Lanzhou · Nanjing Drum Tower hospital, Nanjing · The First Hospital of China Medical University, Shenyang · Tianjin Medical University General Hospital, Tianjin · Ying han, Xi'an

    Registry updated 2026-01-08

  • NCT06755151

    Fenofibrate in Primary Biliary Cholangitis: a Real World Study

    Trial Treatment · Phase 3 · Xijing Hospital of Digestive Diseases

    Xijing hospital, Xi'an

    Registry updated 2026-01-08

  • NCT06755541

    Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

    Trial Treatment · Phase 3 · Xijing Hospital of Digestive Diseases

    Xijing hospital, Xi'an

    Registry updated 2026-01-08

  • NCT07149675

    PBC Long-term Outcomes Study

    Research · Beijing Friendship Hospital

    Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing

    Registry updated 2025-09-02

  • NCT04650243

    Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

    Trial Treatment · Phase 4 · Peking Union Medical College Hospital

    Peking Union Medical College Hospital, Beijing

    Registry updated 2025-04-01

All Primary biliary cholangitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Primary biliary cholangitis trials in China – Frontlight Research